GO:0006366 transcription by RNA polymerase II: Gene Expression Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006366 transcription by RNA polymerase II describes the synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), starting at an RNA polymerase II promoter.
• RNAP II transcription produces messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs), making it central to gene expression.
• The process is divided into initiation, promoter escape, elongation, and termination, each controlled by distinct factors such as TFIIH, P-TEFb, and Integrator.
• Elongation is tightly coupled to RNA processing and quality control, including capping, splicing, and 3' end formation.
• Dysregulation of RNAP II transcription is linked to cancer, developmental disorders, and neurodegeneration.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal testing of transcription-related genes.
Description
Transcription by RNA polymerase II (GO:0006366) is the biological process that synthesizes RNA from a DNA template using RNA polymerase II (RNAP II), beginning at an RNA polymerase II promoter. This process is responsible for producing messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs), and it is the first and most heavily regulated step in gene expression. Because RNAP II transcription determines which proteins a cell can make, its mechanisms are fundamental to development, homeostasis, and disease. Researchers study GO:0006366 to understand how genes are switched on and off, how RNA processing is coordinated with transcription, and how errors in these steps contribute to human disorders. The process is not a single event but a cycle of initiation, elongation, and termination, each with dedicated protein factors and regulatory checkpoints. Advances in genomic methods such as capped small RNA sequencing (csRNA-seq) now allow precise mapping of active RNAP II transcription start sites from total RNA, making the process increasingly tractable for experimental dissection.
transcription by RNA polymerase II At A Glance
| GO ID | GO:0006366 |
|---|---|
| GO term | transcription by RNA polymerase II |
| Ontology | biological_process |
| Synonym | transcription from RNA polymerase II promoter; transcription from Pol II promoter; general transcription from RNA polymerase II promoter; gene-specific transcription from RNA polymerase II promoter; specific transcription from RNA polymerase II promoter; RNA polymerase II transcription factor activity |
| Major function | Synthesis of mRNA and certain snRNAs from a DNA template by RNAP II |
| Key stages | Initiation, promoter escape, elongation, termination |
| Coupled processes | RNA capping, splicing, 3' end formation, and RNA quality control |
| Major regulators | P-TEFb, Integrator complex, ARS2-ZC3H4 |
| Disease relevance | Cancer, developmental disorders, neurodegeneration |
What Is GO:0006366?
GO:0006366 transcription by RNA polymerase II is defined as the synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. It includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs). In practice, this term covers the full transcription cycle: recruitment of RNAP II to promoters, initiation of RNA synthesis, promoter escape, elongation with coupled RNA processing, and termination.
Why Is transcription by RNA polymerase II Important in Cell Biology?
RNA polymerase II transcription is the central step that converts genetic information into functional RNA and protein, and its regulation determines cell identity, responses to signals, and developmental outcomes. Because RNAP II transcription is coupled to RNA processing and quality control, defects in this process can produce aberrant transcripts that contribute to disease. Understanding GO:0006366 is therefore essential for interpreting gene expression data, designing experiments that manipulate transcription, and developing therapies that target transcriptional dependencies in cancer and other disorders.
• Controls expression of most protein-coding genes and many regulatory noncoding RNAs.
• Integrates signals from enhancers, promoters, and chromatin to determine cell fate.
• Couples transcription with RNA capping, splicing, and 3' end processing.
• Provides targets for therapeutic intervention in cancer and developmental disease.
• Is required for production of snRNAs involved in splicing.
• Dysregulation leads to transcriptional addiction in tumors.
• Serves as a readout for gene regulatory networks in functional genomics.
• Enables experimental mapping of active transcription start sites via csRNA-seq.
• Links RNA quality control to transcription elongation.
• Is a major source of regulatory complexity in plants and animals.
What Happens During transcription by RNA polymerase II?
Initiation and promoter recognition
In simple terms: RNA polymerase II finds the start of a gene and begins making RNA.
Initiation begins when RNAP II is recruited to an RNA polymerase II promoter with the help of general transcription factors. The process requires promoter recognition and formation of a preinitiation complex, after which RNA synthesis starts. This step is a major point of regulation because it determines whether a gene will be transcribed.
Promoter escape and early elongation
In simple terms: The polymerase leaves the starting line and starts moving along the gene.
After initiation, RNAP II must escape the promoter and transition into productive elongation. This transition is regulated by factors including P-TEFb, which phosphorylates the RNAP II C-terminal domain and promotes elongation. Early elongation is also a checkpoint where RNA quality control can influence whether transcription continues.
Elongation and coupled RNA processing
In simple terms: The polymerase travels along DNA while the new RNA is processed.
During elongation, RNAP II synthesizes RNA while coordinating with capping, splicing, and other processing events. The Integrator complex is a multitasking regulator that controls transcription and RNA processing at this stage. In plants, elongation factors and their regulation have major impacts on gene expression.
Termination and RNA 3' end formation
In simple terms: The polymerase stops at the end of the gene and releases the RNA.
Termination of RNAP II transcription involves DNA-directed mechanisms and is coupled to 3' end processing of the transcript. Termination of short noncoding RNAs by RNAP II is also a regulated process. ARS2 and ZC3H4 can instruct early termination-coupled RNA decay, linking termination to RNA quality control.
RNA quality control and surveillance
In simple terms: The cell checks the new RNA and destroys defective copies.
RNAP II transcription is coupled to RNA quality control pathways that detect and degrade aberrant transcripts. This coupling ensures that only properly processed RNAs accumulate, and it involves factors such as ARS2 and ZC3H4. The Integrator complex also participates in these surveillance mechanisms.
Key Genes Involved in GO:0006366 transcription by RNA polymerase II
The following genes and proteins are central to RNA polymerase II transcription and are commonly studied in functional genomics research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POLR2A | Largest subunit of RNA polymerase II | Core catalytic subunit; target for transcription inhibition studies |
| CDK9 | Kinase subunit of P-TEFb | Regulates elongation; target in cancer and inflammation |
| CCNT1 | Cyclin T1, partner of CDK9 | Forms P-TEFb complex; regulates transcription elongation |
| CDK7 | Kinase subunit of TFIIH | Phosphorylates RNAP II CTD during initiation |
| INTS11 | Integrator complex subunit | Controls transcription and RNA processing |
| SRRT | ARS2 protein | Recruits ZC3H4 for early termination-coupled decay |
| ZC3H4 | Termination factor | Promotes early transcription termination and RNA decay |
| CTD | C-terminal domain of RNAP II | Phosphorylation platform for transcription regulation |
| TFIIH | General transcription factor | Required for initiation and promoter escape |
| ELL2 | Elongation factor | Enhances RNAP II elongation |
| AFF4 | Scaffold of super elongation complex | Regulates elongation in development and disease |
| MLLT3 | Super elongation complex component | Links transcription elongation to leukemia |
| BRD4 | Bromodomain protein | Recruits P-TEFb to chromatin |
| MED1 | Mediator subunit | Connects enhancers to RNAP II |
| XRN2 | 5'-3' exonuclease | Functions in termination and RNA processing |
| SETX | RNA/DNA helicase | Linked to termination and neurodegeneration |
| CPSF | Cleavage and polyadenylation factor | Couples 3' end processing to termination |
How Is transcription by RNA polymerase II Regulated?
RNA polymerase II transcription is regulated at multiple levels, including promoter recruitment, pause release, and elongation rate. P-TEFb is a master regulator of elongation, and its activity is controlled by interactions with BRD4 and other factors. The Integrator complex regulates both transcription and RNA processing, providing a checkpoint for gene expression. In plants, elongation factors and their regulation affect gene expression in response to developmental and environmental cues. Termination is also regulated, with DNA-directed mechanisms and factors such as ARS2 and ZC3H4 controlling transcript fate.
transcription by RNA polymerase II and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CDK9 | Leukemia and transcriptional addiction | Knockout and point-mutation cell models |
| INTS11 | Developmental disorders and cancer | Knockout and knock-in models |
| SETX | Neurodegeneration (ALS4-like) | Point-mutation knock-in models |
| SRRT (ARS2) | RNA processing and decay defects | Knockout and overexpression models |
| ZC3H4 | Transcriptional termination and RNA decay | Knockout and tagged knock-in models |
Cancer and transcriptional addiction
Many cancers depend on high levels of RNAP II transcription for growth and survival. P-TEFb and its regulators are frequently dysregulated in leukemia and solid tumors, making elongation control a therapeutic target. The Integrator complex has also been implicated in cancer through its roles in transcription and RNA processing.
Neurodegeneration and RNA processing defects
Defects in transcription termination and RNA quality control can lead to neurodegeneration. For example, SETX mutations are associated with neurological disease, and termination factors such as XRN2 are linked to RNA processing defects. ARS2-ZC3H4-mediated decay pathways also protect against aberrant transcripts that could contribute to neuronal dysfunction.
Developmental disorders and transcriptional dysregulation
Proper regulation of RNAP II transcription is essential for development. Mutations in elongation factors and Integrator subunits can cause developmental syndromes due to disrupted gene expression programs. Studying these genes in model systems helps link transcriptional mechanisms to disease phenotypes.
From transcription by RNA polymerase II-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a transcription factor essential for cell viability? | CRISPR knockout cell line |
| Does a point mutation alter elongation activity? | CRISPR point-mutation knock-in |
| How does a fusion protein affect transcription? | CRISPR knock-in of tagged or fusion allele |
| Does overexpression drive transcriptional addiction? | CRISPR overexpression (safe-harbor insertion) |
| Where does a factor bind on chromatin? | Endogenous tagged knock-in for ChIP or imaging |
| Which genes depend on a transcription regulator? | CRISPR library screening and RNA-seq |
How to Study the transcription by RNA polymerase II Process
| Method | What It Measures | Typical Application |
|---|---|---|
| csRNA-seq | Active RNAP II transcription start sites | Promoter and enhancer mapping |
| RNA-seq | Steady-state and nascent RNA levels | Gene expression profiling |
| ChIP-seq | Chromatin occupancy of RNAP II and factors | Transcription factor binding |
| PRO-seq | Nascent RNA polymerase activity | Elongation and pause analysis |
| Mass spectrometry | Protein interactions and complexes | Transcription machinery composition |
| Live-cell imaging | Transcription dynamics in real time | Single-cell regulation |
| CRISPR screening | Gene dependencies for transcription | Functional genomics |
Mapping active transcription start sites
Capped small RNA sequencing (csRNA-seq) profiles active RNA polymerase II transcription start sites from total RNA, enabling genome-wide detection of transcription initiation events. This method is useful for identifying promoters and enhancers that are actively engaged by RNAP II.
Measuring transcription and RNA processing
RNA-seq and related approaches quantify nascent and mature transcripts to assess elongation, termination, and processing defects. Coupling these methods with knockdown or knockout of transcription factors reveals their impact on gene expression.
Proteomics and interaction studies
Affinity purification and mass spectrometry can identify protein complexes associated with RNAP II and its regulators, such as P-TEFb and Integrator. These approaches help define the composition of transcription machinery in different cell states.
Imaging and live-cell assays
Fluorescence imaging of tagged RNAP II or transcription factors allows visualization of transcription dynamics in single cells. These methods complement genomic approaches by revealing spatial and temporal regulation.
How CRISPR Can Be Used to Study GO:0006366 transcription by RNA polymerase II
Knockout
CRISPR knockout of transcription-related genes such as CDK9 or INTS11 can reveal essential functions in RNAP II transcription and cell viability. Knockout models are widely used to test whether a factor is required for elongation or termination.
Point Mutation
Point-mutation knock-in can dissect specific residues required for kinase activity or protein interactions, such as those in CDK9 or RNAP II subunits. These models help distinguish catalytic from scaffolding functions.
Knock-in
Knock-in of tags or reporter sequences allows tracking of endogenous transcription factors and RNAP II in live cells. This approach is valuable for imaging and chromatin immunoprecipitation studies.
Overexpression
Overexpression of transcription regulators such as P-TEFb components can model transcriptional addiction and identify downstream gene expression changes. Overexpression models are useful for testing gain-of-function effects in cancer and development.
How EDITGENE Supports transcription by RNA polymerase II Research
Researchers studying transcription by RNA polymerase II-related genes often need to determine whether a candidate gene is causally involved in transcription regulation, RNA processing, or disease. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for transcription by RNA polymerase II research.
Frequently Asked Questions About transcription by RNA polymerase II
What is transcription by RNA polymerase II?
It is the synthesis of RNA from a DNA template by RNA polymerase II, starting at an RNA polymerase II promoter, and includes mRNA and certain snRNA production.
What genes are involved in transcription by RNA polymerase II?
Key genes include POLR2A, CDK9, CCNT1, CDK7, INTS11, SRRT, and ZC3H4, among others.
What is the GO ID for transcription by RNA polymerase II?
The GO ID is GO:0006366.
What are the stages of RNA polymerase II transcription?
The main stages are initiation, promoter escape, elongation, and termination, with coupled RNA processing.
How is RNA polymerase II transcription regulated?
It is regulated by factors such as P-TEFb, the Integrator complex, and termination factors like ARS2 and ZC3H4.
Why is RNA polymerase II transcription important in cancer?
Many cancers depend on high transcriptional activity, and regulators like P-TEFb are linked to leukemia and other tumors.
What methods study RNA polymerase II transcription?
csRNA-seq, RNA-seq, ChIP-seq, PRO-seq, mass spectrometry, and imaging are commonly used.
How can CRISPR be used to study transcription by RNA polymerase II?
CRISPR knockout, point mutation, knock-in, and overexpression models can test the function of transcription-related genes.
What diseases are linked to defects in RNA polymerase II transcription?
Cancer, neurodegeneration, and developmental disorders have been linked to transcription dysregulation.
What is the role of P-TEFb in transcription?
P-TEFb is a master regulator of transcription elongation that phosphorylates RNAP II and promotes productive elongation.
Conclusion
GO:0006366 transcription by RNA polymerase II is a foundational biological process that produces mRNA and certain snRNAs and is essential for gene expression. Its multi-step cycle, from initiation to termination, is tightly regulated and coupled to RNA processing and quality control. Understanding this process is critical for interpreting gene regulation in health and disease, and CRISPR-based models provide powerful tools to dissect its mechanisms.
References
- 1. Han Z et al.. 2023. DNA-directed termination of RNA polymerase II transcription.. Mol Cell 83(18):3253-3267.e7 PMID: 37683646
- 2. Fujinaga K et al.. 2023. P-TEFb: The master regulator of transcription elongation.. Mol Cell 83(3):393-403 PMID: 36599353
- 3. Arndt KM et al.. 2015. Termination of Transcription of Short Noncoding RNAs by RNA Polymerase II.. Annu Rev Biochem 84:381-404 PMID: 25747400
- 4. Obermeyer S et al.. 2024. Transcript elongation by RNA polymerase II in plants: factors, regulation and impact on gene expression.. Plant J 118(3):645-656 PMID: 36703573
- 5. Peck SA et al.. 2019. Writing a wrong: Coupled RNA polymerase II transcription and RNA quality control.. Wiley Interdiscip Rev RNA 10(4):e1529 PMID: 30848101
- 6. Meyer MK et al.. 2026. Profiling active RNA polymerase II transcription start sites from total RNA by capped small RNA sequencing (csRNA-seq).. Nat Protoc 21(6):2588-2612 PMID: 41540114
- 7. Rouvière JO et al.. 2023. ARS2 instructs early transcription termination-coupled RNA decay by recruiting ZC3H4 to nascent transcripts.. Mol Cell 83(13):2240-2257.e6 PMID: 37329882
- 8. Welsh SA et al.. 2023. Genomic regulation of transcription and RNA processing by the multitasking Integrator complex.. Nat Rev Mol Cell Biol 24(3):204-220 PMID: 36180603
